Krsnaa Diagnostics Limited (NSE:KRSNAA)
India · Delayed Price · Currency is INR 561.65
+11.65 (2.12%)
Aug 21, 2026, 3:29 PM IST
Krsnaa Diagnostics Market Cap
Krsnaa Diagnostics has a market cap or net worth of 18.22 billion as of August 21, 2026. Its market cap has decreased by -31.51% in one year.
Market Cap
18.22B
Enterprise Value
19.96B
Revenue
8.41B
Ranking
n/a
PE Ratio
18.93
Stock Price
561.65
ChartMarket Cap Chart
Since August 16, 2021, Krsnaa Diagnostics's market cap has decreased from 30.99B to 18.22B, a decrease of -41.21%. That is a compound annual growth rate of -10.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 18.22B | -22.14% |
| Dec 31, 2025 | 23.40B | -18.16% |
| Dec 31, 2024 | 28.59B | 25.42% |
| Dec 29, 2023 | 22.80B | 57.53% |
| Dec 30, 2022 | 14.47B | -37.50% |
| Dec 31, 2021 | 23.15B | -25.28% |
| Aug 16, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.57T |
| Divi's Laboratories | 2.28T |
| Apollo Hospitals Enterprise | 1.26T |
| Cipla | 1.16T |
| Indoco Remedies | 20.55B |
| Windlas Biotech | 20.39B |
| Sakar Healthcare | 19.68B |
| Tarsons Products | 17.95B |